{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:17:34Z","timestamp":1787062654006,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T00:00:00Z","timestamp":1441929600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0924-6","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T11:17:55Z","timestamp":1441970275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Ecosse L.","family":"Lamoureux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Mcintosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Constantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva K.","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Casson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghee Soon","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Pesudovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Crowston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,11]]},"reference":[{"key":"924_CR1","first-page":"887","volume":"82","author":"InFocus","year":"2004","unstructured":"InFocus. Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 2004;82:887.","journal-title":"Bull World Health Organ"},{"key":"924_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262\u20137.","journal-title":"Br J Ophthalmol."},{"key":"924_CR3","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1167\/iovs.12-10258","volume":"54","author":"EW Chan","year":"2013","unstructured":"Chan EW, Chiang PP, Wong TY, Saw SM, Loon SC, Aung T, et al. Impact of glaucoma severity and laterality on vision-specific functioning: the Singapore Malay eye study. Invest Ophthalmol Vis Sci. 2013;54:1169\u201375.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"924_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ajo.2011.06.004","volume":"152","author":"R Varma","year":"2011","unstructured":"Varma R, Lee PP, Goldberg I, Kotak S. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol. 2011;152:515\u201322.","journal-title":"Am J Ophthalmol."},{"key":"924_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpsychores.2013.03.005","volume":"75","author":"C Zhou","year":"2013","unstructured":"Zhou C, Qian S, Wu P, Qiu C. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical, and self-reported correlates. J Psychosom Res. 2013;75:75\u201382.","journal-title":"J Psychosom Res."},{"key":"924_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/IJG.0b013e31806540a1","volume":"16","author":"MV Boland","year":"2007","unstructured":"Boland MV, Quigley HA. Risk factors and open-angle glaucoma: concepts and applications. J Glauc. 2007;16:406\u201318.","journal-title":"J Glauc."},{"key":"924_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","volume":"112","author":"CM Olthoff","year":"2005","unstructured":"Olthoff CM, Schouten J, van de Borne B, Webers C. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence based review. Ophthalmology. 2005;112:953\u201361.","journal-title":"Ophthalmology."},{"key":"924_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","volume":"140","author":"BL Nordstrom","year":"2005","unstructured":"Nordstrom BL, Friedman D, Mozaffari E, Quigley H, Walker A. Persistence and adherance with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598\u2013606.","journal-title":"Am J Ophthalmol."},{"key":"924_CR9","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1136\/bjo.2003.037713","volume":"88","author":"Z Zhou","year":"2004","unstructured":"Zhou Z, Althin R, Sforzolini B, Dhawan R. Persistency and treatment failure in newly diagnosed open-angle glaucoma patients in the United Kingdom. Br J Ophthalmol. 2004;88:1391\u20134.","journal-title":"Br J Ophthalmol."},{"key":"924_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","volume":"83","author":"JH Gurwitz","year":"1993","unstructured":"Gurwitz JH, Glynn R, Monane M, Everitt D, Gilden D, Smith N, et al. Treatment for Glaucoma: Adherance by the Elderly. Am J Pub Health. 1993;83:711\u20136.","journal-title":"Am J Pub Health."},{"key":"924_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1600-0420.2005.00560.x","volume":"84","author":"B Lindblom","year":"2006","unstructured":"Lindblom B, Nordmann J, Sellem E, Chen E, Gold R, Polland W, et al. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden. Acta Ophthalmol Scand. 2006;84:74\u201383.","journal-title":"Acta Ophthalmol Scand."},{"key":"924_CR12","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1185\/03007990802379996","volume":"24","author":"L Cantor","year":"2008","unstructured":"Cantor L, Katz L, Cheng J, Chen E, Tong K, Peabody J. Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US. Curr Med Res Opin. 2008;24:2905\u201318.","journal-title":"Curr Med Res Opin."},{"key":"924_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","volume":"143","author":"B Miljanovic","year":"2007","unstructured":"Miljanovic B, Dana R, Sullivan DA, Schaumberg D. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409\u201315.","journal-title":"Am J Ophthalmol."},{"key":"924_CR14","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/S0140-6736(95)90116-7","volume":"345","author":"P Diggory","year":"1995","unstructured":"Diggory P, Cassels-Brown A, Vail A, Abbey LM, Hillman JS. Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents. Lancet. 1995;345:1604\u20136.","journal-title":"Lancet."},{"key":"924_CR15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","volume":"29","author":"RD Fechtner","year":"2010","unstructured":"Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of Ocular Surface Complaints in Patients with Glaucoma using Topical Intraocular Pressure-Lowering Medications. Cornea. 2010;29:618\u201321.","journal-title":"Cornea."},{"key":"924_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/ICU.0b013e328089f1c8","volume":"18","author":"RW Yee","year":"2007","unstructured":"Yee RW. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review. Curr Opin Ophthalmol. 2007;18:134\u20139.","journal-title":"Curr Opin Ophthalmol."},{"key":"924_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","volume":"17","author":"EW Leung","year":"2008","unstructured":"Leung EW, Medeiros FA, Weinreb RN. Prevalence of Ocular Surface Disease in Glaucoma Patients. J Glauc. 2008;17:350\u20135.","journal-title":"J Glauc."},{"key":"924_CR18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0095-4543(21)01100-3","volume":"16","author":"GO Williams","year":"1989","unstructured":"Williams GO. Management of depression in the elderly. Prim Care. 1989;16:451\u201374.","journal-title":"Prim Care."},{"key":"924_CR19","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1185\/030079907X233287","volume":"23","author":"JK Schmier","year":"2007","unstructured":"Schmier JK, Covert DW, Rogin AL. Estimated first-year costs of prostaglandin analogs with\/without adjunctive therapy for glaucoma management: a United States perspective. Curr Med Res Opin. 2007;23:2867\u201375.","journal-title":"Curr Med Res Opin."},{"key":"924_CR20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/bmj.332.7547.960","volume":"332","author":"ME Muller","year":"2006","unstructured":"Muller ME, van der Velde N, Krulder JWM, van der Cammen TJM. Syncope and falls due to timolol eye drops. BMJ. 2006;332:960\u20131.","journal-title":"BMJ."},{"key":"924_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/bjo.82.1.39","volume":"82","author":"C Baudouin","year":"1998","unstructured":"Baudouin C, deLunardo C. Short-term comparative study of topical 2 % carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol. 1998;82:39\u201342.","journal-title":"Br J Ophthalmol."},{"key":"924_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ajo.2010.03.012","volume":"150","author":"JA Alvarado","year":"2010","unstructured":"Alvarado JA, Iguchi R, Martinez J, Trivedi S, Shifera AS. Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells. Am J Ophthalmol. 2010;150:254\u201364.","journal-title":"Am J Ophthalmol."},{"key":"924_CR23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1001\/archophthalmol.2010.85","volume":"128","author":"JA Alvarado","year":"2010","unstructured":"Alvarado JA, Katz LJ, Trivedi S, Shifera AS. Monocyte modulation of aqueous outflow and recruitment to the trabecular meshwork following selective laser trabeculoplasty. Arch Ophthalmol. 2010;128:731\u20137.","journal-title":"Arch Ophthalmol."},{"key":"924_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0161-6420(00)00660-6","volume":"108","author":"TR Kramer","year":"2001","unstructured":"Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001;108:773\u20139.","journal-title":"Ophthalmology."},{"key":"924_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1442-9071.2004.00839.x","volume":"32","author":"JSM Lai","year":"2004","unstructured":"Lai JSM, Chua JKH, Tham CCY, Lam DSC. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Exp Ophthalmol. 2004;32:368\u201372.","journal-title":"Clin Exp Ophthalmol."},{"key":"924_CR26","first-page":"1","volume":"00","author":"LJ Katz","year":"2011","unstructured":"Katz LJ, Steinmann WC, Kabir A, Molineaux J, Wizov SS, Marcellino G, et al. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: A Prospective Randomized Trial. J Glauc. 2011;00:1\u20139.","journal-title":"J Glauc."},{"key":"924_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/bjo.2008.148510","volume":"93","author":"M Nagar","year":"2009","unstructured":"Nagar M, Luhishi E, Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. Br J Ophthalmol. 2009;93:497\u2013501.","journal-title":"Br J Ophthalmol."},{"key":"924_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archophthalmol.2012.355","volume":"130","author":"MI Seider","year":"2012","unstructured":"Seider MI, Keenan JD, Han Y. Cost of Selective Laser Trabeculoplasty vs Topical Medications for Glaucoma. Arch Ophthalmol. 2012;130:529\u201330.","journal-title":"Arch Ophthalmol."},{"key":"924_CR29","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00417-011-1779-5","volume":"249","author":"H Sawada","year":"2011","unstructured":"Sawada H, Fukuchi T, Abe H. Evaluation of the relationship between quality of vision and the visual function index in Japanese glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2011;249:1721\u201327.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"924_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/sj.eye.6700036","volume":"16","author":"M Iester","year":"2002","unstructured":"Iester M, Zingirian M. Quality of life in patients with early, moderate and advanced glaucoma. Eye. 2002;16:44\u20139.","journal-title":"Eye."},{"key":"924_CR31","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.ophtha.2007.08.037","volume":"115","author":"R McKean-Cowdin","year":"2007","unstructured":"McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R, Group LALES. Impact of Visual Field Loss on Health-Related Quality of Life in Glaucoma: The Los Angeles Latino Eye Study. Ophthalmology. 2007;115:941\u20138.","journal-title":"Ophthalmology."},{"key":"924_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00061198-200106000-00008","volume":"10","author":"RP Mills","year":"2001","unstructured":"Mills RP, Janz NK, Wren PA, Guire KE, Group CS. Correlation of Visual Field With Quality-of-Life Measures at Diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J Glauc. 2001;10:192\u20138.","journal-title":"J Glauc."},{"key":"924_CR33","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1046\/j.1442-9071.2003.00712.x","volume":"31","author":"G No\u00eb","year":"2003","unstructured":"No\u00eb G, Ferraro J, Lamoureux E, Rait J, Keeffe JE. Associations between glaucomatous visual field loss and participation in activities of daily living. Clin Experiment Ophthalmol. 2003;31:482\u20136.","journal-title":"Clin Experiment Ophthalmol."},{"key":"924_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1600-0420.1997.tb00154.x","volume":"75","author":"PE Wandell","year":"1997","unstructured":"Wandell PE, Lundstrom M, Brorsson B, Aberg H. Quality of life among patients with glaucoma in Sweden. Acta Ophthalmol Scand. 1997;75:584\u20138.","journal-title":"Acta Ophthalmol Scand."},{"key":"924_CR35","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ajo.2008.10.007","volume":"147","author":"P Rn","year":"2009","unstructured":"Rn P, Feuer W, Schiffman J, Lichter P, Musch D. CIGTS Optic Disc Study Group. Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol. 2009;147:717\u201324.","journal-title":"Am J Ophthalmol"},{"key":"924_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/IJG.0b013e318287ac11","volume":"24","author":"J Khadka","year":"2015","unstructured":"Khadka J, McAlinden C, Craig JE, Fenwick EK, Lamoureux EL, Pesudovs K. Identifying Content for the Glaucoma-specific Item Bank to Measure Quality-of-life Parameters. J Glaucoma. 2015;24:12\u20139.","journal-title":"J Glaucoma."},{"key":"924_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11136-007-9204-6","volume":"16","author":"D Cella","year":"2007","unstructured":"Cella D, Gershon R, Lai JS, Choi S. The futurue of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res. 2007;16:133\u201341.","journal-title":"Qual Life Res."},{"key":"924_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1600-0420.2007.00999.x","volume":"86","author":"A Bechetoille","year":"2008","unstructured":"Bechetoille A, Arnould B, Bron A, Baudouin C, Renard JP, Sellem E, et al. Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire. Acta Ophthalmol Scand. 2008;86:71\u201380.","journal-title":"Acta Ophthalmol Scand."},{"key":"924_CR39","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1167\/iovs.04-1389","volume":"46","author":"R Misajon","year":"2005","unstructured":"Misajon R, Hawthorne G, Richardson J, Barton J, Peacock S, Iezzi A, et al. Vision and quality of life: the development of a utility measure. Invest Ophthalmol Vis Sci. 2005;46:4007\u201315.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"924_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/09286586.2012.674613","volume":"19","author":"J Richardson","year":"2012","unstructured":"Richardson J, Iezzi I, Peacock S, Sinha K, Khan M, Misajon R, et al. Utility Weights for the Vision-related Assessment of Quality of Life (AQoL)-7D Instrument. Ophthalmic Epidemiol. 2012;19:172\u201382.","journal-title":"Ophthalmic Epidemiol."},{"key":"924_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2466-9-37","volume":"9","author":"R Vempati","year":"2009","unstructured":"Vempati R, Bijlani RL, Deepak KK. The efficacy of a comprehensive lifestyle modification programme based on yoga in the management of bronchial asthma: a randomized controlled trial. BMC Pulm Med. 2009;9:37.","journal-title":"BMC Pulm Med."},{"key":"924_CR42","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1161\/01.STR.0000141977.18520.3b","volume":"35","author":"JW Sturm","year":"2004","unstructured":"Sturm JW, Donnan GA, Dewey HM, Macdonell RA, Gilligan AK, Srikanth V, et al. Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2004;35:2340\u20135.","journal-title":"Stroke."},{"key":"924_CR43","first-page":"10","volume":"71","author":"J Weiss","year":"2003","unstructured":"Weiss J, Shavin J, Davis MW. Overall results of the BEST study following treatment of patients with mild to moderate acne. Cutis. 2003;71:10\u20137.","journal-title":"Cutis."},{"key":"924_CR44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3109\/09638280903349552","volume":"32","author":"K Tyedin","year":"2009","unstructured":"Tyedin K, Cumming TB, Bernhardt J. Quality of life: An important outcome measure in a trial of very early mobilisation after stroke. Disabil Rehabil. 2009;32:875\u201384.","journal-title":"Disabil Rehabil."},{"key":"924_CR45","volume-title":"A user\u2019s guide to Winsteps: Rasch-Model Computer Program","author":"JM Linacre","year":"2002","unstructured":"Linacre JM. A user\u2019s guide to Winsteps: Rasch-Model Computer Program. Chicago, Illinois: MESA Press; 2002."},{"key":"924_CR46","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in Health and Medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996."},{"key":"924_CR47","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/09286580801979417","volume":"15","author":"S Peacock","year":"2008","unstructured":"Peacock S, Misajon R, Iezzi A, Richardson J, Hawthorne G, Keeffe J. Vision and quality of life: development of methods for the VisQoL vision-related utility instrument. Ophthalmic Epidemiol. 2008;15:218\u201323.","journal-title":"Ophthalmic Epidemiol."},{"key":"924_CR48","first-page":"1436","volume":"31","author":"J Walt","year":"1997","unstructured":"Walt J, Rowe M, Stern K. Evaluating the functional Impact of Dry Eye: The Ocular Surface Disease Index. Drug Inf J. 1997;31:1436.","journal-title":"Drug Inf J."},{"key":"924_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.pec.2011.07.002","volume":"86","author":"L Fisher","year":"2012","unstructured":"Fisher L, Hessler D, Naranjo D, Polonsky W. AASAP: a program to increase recruitment and retention in clinical trials. Patient Educ Couns. 2012;86:372\u20137.","journal-title":"Patient Educ Couns."},{"issue":"Suppl","key":"924_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1207\/s15324796abm2902s_9","volume":"29","author":"M Coday","year":"2005","unstructured":"Coday M, Boutin-Foster C, Goldman Sher T, Tennant J, Greaney ML, Saunders SD, et al. Strategies for retaining study participants in behavioral intervention trials: retention experiences of the NIH Behavior Change Consortium. Ann Behav Med. 2005;29(Suppl):55\u201365.","journal-title":"Ann Behav Med"},{"key":"924_CR51","unstructured":"Access Economics Pty Limited: Tunnel Vision: the Economic Impact of Primary Open Angle Glaucoma. Melbourne; 2008."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0924-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T22:22:54Z","timestamp":1718058174000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0924-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,11]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0924-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,11]]},"article-number":"406"}}